Navigating Weight Loss: Can You Take Mounjaro with No Gallbladder?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has become a cornerstone treatment for weight loss, with clinical trials showing weight reductions of 20-22% in some participants. If you've had your gallbladder removed—a condition affecting roughly 600,000 Americans annually—you may wonder whether tirzepatide remains a safe and effective option for your weight loss journey. This article explores the relationship between GLP-1 receptor agonists, gallbladder function, and personalized treatment planning.

How Tirzepatide Affects Digestion and Bile Flow

Tirzepatide slows stomach emptying and reduces appetite by activating GLP-1 and GIP receptors in the brain and pancreas. This mechanism causes food to move more gradually through your digestive tract, which changes the timing and volume of bile release into the small intestine. Without a gallbladder, your liver still produces bile but cannot store and concentrate it for meals, meaning bile flows continuously rather than in pulses.

When bile flow timing shifts due to GLP-1 agonist use, patients without a gallbladder may experience changes in digestion efficiency and stool consistency. Some report looser stools or increased urgency, particularly during the first weeks of treatment. These effects typically stabilize as your body adjusts to the medication, though individual experiences vary based on baseline digestive health and diet composition.

Gallbladder Removal and GLP-1 Medication Safety

Clinical evidence does not contraindicate GLP-1 receptor agonists—including tirzepatide—in patients with prior cholecystectomy (gallbladder removal). The FDA-approved tirzepatide trials included participants with varied surgical histories, and post-marketing surveillance has not identified safety signals specific to gallbladder-absent populations. However, this population requires closer monitoring for digestive tolerance and symptom changes.

Your healthcare provider may recommend a slower dose titration schedule if you've had your gallbladder removed. Starting at a lower maintenance dose allows your body to adapt to altered bile flow patterns while the GLP-1 medication simultaneously slows gastric transit. PlexusDx compounded tirzepatide injections begin at $289/mo (or $249/mo on the 6-month plan) across all commitment tiers, enabling flexible dosing adjustments without price escalation as your provider modifies your prescription.

Managing Digestive Side Effects Without a Gallbladder

Loose stools and urgency commonly affect GLP-1 users regardless of gallbladder status, but patients without a gallbladder may experience these effects more frequently or intensely. Dietary adjustments—including reduced fat intake, increased soluble fiber, and smaller meal portions—can significantly ease symptoms. Working with a registered dietitian familiar with GLP-1 therapy helps you identify trigger foods and optimize nutrient absorption in your altered digestive system.

Hydration becomes especially important when taking tirzepatide without a gallbladder, as changes in bile flow and stool consistency increase fluid losses. Electrolyte balance matters too; discuss supplementation of sodium and potassium with your healthcare team if you experience frequent loose stools. Probiotics may support gut health, though evidence remains mixed—ask your provider which strains have the strongest research backing for your specific situation.

Personalized Treatment Planning at PlexusDx

PlexusDx offers compounded tirzepatide injections through licensed 503A pharmacies, serving all 50 states without insurance requirements or membership fees. Your prescription can be tailored to your medical history, including prior gallbladder removal, with dose adjustments guided by your PlexusDx-affiliated clinician. HSA and FSA funds cover these medications, improving affordability for eligible patients.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide safe to use if I've had my gallbladder removed?

Yes, tirzepatide is not contraindicated in patients with prior cholecystectomy. However, your PlexusDx clinician may recommend a slower titration schedule and closer monitoring of digestive symptoms. Individual tolerance varies, and dietary adjustments often help manage any changes in digestion.

Will tirzepatide make loose stools worse if I don't have a gallbladder?

Altered bile flow in gallbladder-absent patients can increase the likelihood or severity of loose stools when starting GLP-1 therapy. Working with a dietitian to reduce fat intake, increase soluble fiber gradually, and maintain hydration typically minimizes this side effect within 2–4 weeks of consistent medication use.

How much does compounded tirzepatide cost at PlexusDx?

PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan across all commitment tiers. Your dose may increase over time as your clinician adjusts your prescription, but your monthly price remains flat. HSA and FSA accounts are eligible for payment.

What does the PlexusDx Precision Peptide Genetic Test measure?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Should I wait longer between dose increases if I don't have a gallbladder?

Many PlexusDx clinicians recommend extended intervals (4–6 weeks instead of the standard 3–4 weeks) between tirzepatide dose increases for post-cholecystectomy patients. This allows your digestive system time to adapt to both the medication and your altered bile physiology, improving tolerability and treatment adherence.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.